Year-long effort brings in Talcid for BBDO/CNUAC
<p>SHANGHAI: BBDO/CNUAC has dealt a blow to Dentsu Young & Rubicam by </p><p>snagging the Bayer China's over-the-counter antacid brand Talcid, an </p><p>account estimated to be worth about USdollars 2 million. </p><p><BR><BR> </p><p>BBDO, which is Bayer's regional agency, took the account after a </p><p>year-long effort to lure the client away from DY&R culminated in a pitch </p><p>that focused on creative and strategic credentials. </p><p><BR><BR> </p><p>BBDO/CNUAC Shanghai managing director Lau Seng Yee said an integrated </p><p>campaign is being planned. </p><p><BR><BR> </p><p>"We will produce a campaign driven primarily by a series of TV </p><p>commercials. In addition, the campaign will be supported with integrated </p><p>elements both at the consumer level as well as the prescription channel. </p><p>The objective of the campaign is to reinforce the fast relief function </p><p>of the product." </p><p><BR><BR> </p>
Please sign in below or access limited articles a month after free, fast registration.
If you don’t yet have an account, you can register for free to unlock additional content. For full access to everything we offer, view our subscription plans.
Sign In
Register for free
✓ Access limited free articles each month
✓ Email bulletins – top industry news and insights delivered straight to your inbox
Subscribe
✓ Unlimited access to all Campaign Asia content
✓ Real-world campaign case studies and career insights
✓ Exclusive reports, industry news, and annual features